SEP 12, 2016 12:16 PM PDT

Cone Snail Venom may Improve Diabetes Therapeutics

WRITTEN BY: Carmen Leitch
The cone snail has been recognized as a natural born killer. While it moves incredibly slowly, it doesn’t have to rush. It’s able to secrete toxic venom that totally incapacitates its victim. The snail cone can be seen in action in the video below. While researchers have known that the venom could have potential as a painkiller, use in insulin therapy for diabetes is now being investigated.
 

 
Working in collaboration, researchers in the United States and Australia have elucidated the 3D structure of snail cone venom. They have demonstrated that these natural proteins, called Con-Ins G1, are able to act faster than human insulin. The researchers also found that Con-Ins G1 is able to bind receptors for human insulin, indicating it has great potential for therapeutic use in humans.

Leading the research was Associate Professor Mike Lawrence of Melbourne's Walter and Eliza Hall Institute of Medical Research, working with scientists at the University of Utah, the Monash Institute of Pharmaceutical Sciences, La Trobe University and Flinders University in Australia. Lawrence is a specialist in insulin and insulin receptor structure. The teams took advantage of the Australian Synchrotron to both determine and analyze the three-dimensional structure of the cone snail venom insulin protein, and generated some exciting data.
 
This is a Marine cone snail: conus geographus. / Credit: Professor B. Olivera, University of Utah.

"We found that cone snail venom insulins work faster than human insulins by avoiding the structural changes that human insulins undergo in order to function -- they are essentially primed and ready to bind to their receptors, " explained Lawrence.

Lawrence commented that by comparison, human insulins could be considered clunky. "The structure of human insulins contain an extra 'hinge' component that has to open before any 'molecular handshake' or connection between insulin and receptor can take place.
 
Cone snail venom insulin is able bind to human insulin receptors, signifying the potential for its translation into a human therapeutic. / Credit: Walter and Eliza Hall Institute of Medical Research

"By studying the three-dimensional structure of this snail venom insulin we've found how to dispense with this 'hinge' entirely, which may accelerate the cell signaling process and thus the speed with which the insulin takes effect," continued Lawrence.

The findings, which were published in Nature Structural and Molecular Biology, build upon previous work from 2015 in which the team at University of Utah learned that the cone snail Conus geographus utilizes venom based on insulin to trap prey. When unsuspecting fish were targeted, they would become immobilized in a state of hyperglycemic shock caused by the venom. Next was to determine its therapeutic potential.

"We were thrilled to find that the principles of cone snail venom insulins could be applied to a human setting," explained co-author Dr Safavi-Hemami. "Our Flinders University colleagues have shown that the cone snail insulin can 'switch on' human insulin cell signalling pathways, meaning the cone snail insulin is able to successfully bind to human receptors." 

"The next step in our research, which is already underway, is to apply these findings to the design of new and better treatments for diabetes, giving patients access to faster-acting insulins," she concluded.

Sources: AAAS/Eurekalert! via Walter and Eliza Hall Institute of Medical Research, Nature Structural and Molecular Biology
 
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 04, 2020
Cell & Molecular Biology
Why the Effects of a Drug Depend on Who Takes It
OCT 04, 2020
Why the Effects of a Drug Depend on Who Takes It
Many drugs can have a wide range of impacts on the patients that take them; doctors often have to adjust a person's dosa ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
OCT 15, 2020
Neuroscience
Neurometabolism: A bold, new frontier
OCT 15, 2020
Neurometabolism: A bold, new frontier
Billions of neurons communicate with each other through trillions of synapses to create a functioning, unique system we ...
NOV 12, 2020
Genetics & Genomics
Liposomes Potentially Safer Alternative to Viruses for CRISPR Delivery
NOV 12, 2020
Liposomes Potentially Safer Alternative to Viruses for CRISPR Delivery
To repair disease-causing errors in the genome, gene editing reagents like those used in CRISPR-Cas9 first have to reach ...
NOV 25, 2020
Cell & Molecular Biology
Antibacterial Soap Ingredient May Increase Risk of Liver Disease
NOV 25, 2020
Antibacterial Soap Ingredient May Increase Risk of Liver Disease
The triclosan once commonly added to soap was banned by the FDA a few years ago, but it can still be found in some water ...
Loading Comments...